China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review

  • ID: 4319045
  • SWOT Analysis
  • Region: China
  • 43 pages
  • GlobalData
1 of 5
China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

China NT Pharma Group Co Ltd (NT Pharma) is a technology-based pharmaceutical company, which researches, develops, manufactures, and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indications such as cancer; central nervous system disorders; orthopedics; hepatopathy and respiratory disorders. NT Pharma’s branded products include Libod and Xi Di Ke for the treatment of various cancers; Miacalcic for bone pain; Shusi, an antipsychotic drug; Zhuo’ao, a respiratory drug, and Songzhi Wan, a traditional Chinese medicine for the treatment of Hepatitis C. The company operates three production bases for chemical drugs, traditional Chinese medicine and bio-chemical drugs through its subsidiaries, Suzhou First, Jiangsu Biopharma and Changsha Pharma. It operates a research and development facility in Beijing. NT Pharma is headquartered in Wanchai, Hong Kong.

China NT Pharma Group Co Ltd Key Recent Developments

Mar 26, 2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017
Aug 21, 2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017
Jul 31, 2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director
Mar 21, 2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
  • China NT Pharma Group Co Ltd - Key Facts
  • China NT Pharma Group Co Ltd - Key Employees
  • China NT Pharma Group Co Ltd - Key Employee Biographies
  • China NT Pharma Group Co Ltd - Major Products and Services
  • China NT Pharma Group Co Ltd - History
  • China NT Pharma Group Co Ltd - Company Statement
  • China NT Pharma Group Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • China NT Pharma Group Co Ltd - Business Description
  • Business Segment: Miacalcic
  • Overview
  • Performance
  • Business Segment: Proprietary Products Production and Sales and Promotion
  • Overview
  • Performance
  • Geographical Segment: Hong Kong
  • Performance
  • Geographical Segment: Other Countries
  • Performance
  • Geographical Segment: PRC
  • Performance
  • R&D Overview
  • China NT Pharma Group Co Ltd - Corporate Strategy
  • China NT Pharma Group Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • China NT Pharma Group Co Ltd - Strengths
  • China NT Pharma Group Co Ltd - Weaknesses
  • China NT Pharma Group Co Ltd - Opportunities
  • China NT Pharma Group Co Ltd - Threats
  • China NT Pharma Group Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • China NT Pharma Group Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 26, 2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017
  • Aug 21, 2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017
  • Jul 31, 2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director
  • Mar 21, 2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • China NT Pharma Group Co Ltd, Key Facts
  • China NT Pharma Group Co Ltd, Key Employees
  • China NT Pharma Group Co Ltd, Key Employee Biographies
  • China NT Pharma Group Co Ltd, Major Products and Services
  • China NT Pharma Group Co Ltd, History
  • China NT Pharma Group Co Ltd, Subsidiaries
  • China NT Pharma Group Co Ltd, Key Competitors
  • China NT Pharma Group Co Ltd, Ratios based on current share price
  • China NT Pharma Group Co Ltd, Annual Ratios
  • China NT Pharma Group Co Ltd, Annual Ratios
  • China NT Pharma Group Co Ltd, Annual Ratios
  • China NT Pharma Group Co Ltd, Interim Ratios
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • China NT Pharma Group Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • China NT Pharma Group Co Ltd, Performance Chart (2013 - 2017)
  • China NT Pharma Group Co Ltd, Ratio Charts
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Xian-Janssen Pharmaceutical Ltd
  • Sumitomo Pharmaceuticals (Suzhou) Co Ltd
  • Beijing Tiantan Biological Products Co Ltd
  • Beijing SL Pharmaceutical Co Ltd
  • Beijing Beilu Pharmaceutical Co Ltd
  • Anhui Anke Biotechnology (Group) Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll